Cumberland Pharmaceutical... (CPIX)

NasdaqGS: CPIX · Real-Time Price · USD

7.50

-0.15 (-1.96%)

At close: Aug 20, 2026, 3:59 PM

The price, the headline numbers and the latest news, in one place.

-1.96% (1D)

Bid	5.65
Market Cap	112.37M
Revenue (ttm)	44.3M
Net Income (ttm)	-3.2M
	0.11
	-0.22
	n/a
	53.57
P/B (ttm)	6.44
P/S (ttm)	2.54
Earnings Date	Aug 10, 2021

Ask	9.8
Volume	130,194
Avg. Volume (20D)	102,483
Open	7.59
Previous Close	7.65
Day's Range	7.46 - 7.92
52-Week Range	1.85 - 8.45
Analyst	n/a
Price Target	n/a
Dividends	n/a
Ex-Dividend Date	Aug 3, 2026

About CPIX

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Sancuso, a transdermal patch for the prevention of nausea ...

Sector Healthcare

IPO Date Aug 11, 2009

Employees 88

Stock Exchange NasdaqGS

Ticker Symbol CPIX

Website https://www.cumberlandpharma.com

Full Company Profile

Financial Performance

In 2025, Cumberland Pharmaceuticals's revenue was 44.52M, an increase of 17.57% compared to the previous year's 37.87M. Earnings were -2.84M, a decrease of -56.23%.

Financial Statements

Earnings Surprise

Cumberland Pharmaceuticals has released their quarterly earnings on May 11, 2021:

Revenue of $8.8M misses estimates by $0, with -18.79% YoY decline.

EPS of 0.07 exceeds estimates by 0.14, with 600.00% YoY growth.

Next Earnings Release

Cumberland Pharmaceuticals Inc. is scheduled to release its earnings on Aug 10, 2021, after market closes.
Analysts project revenue of ... Upgrade

News

2 weeks ago · GuruFocus.com

Cumberland Pharmaceuticals Inc (CPIX) (Q2 2026) Earnings Call Highlights: Strategic ...

Company closes $100M Apotex deal, declares special dividend, and advances key clinical programs including DMD, systemic sclerosis, and IPF.

2 weeks ago · MarketBeat

Cumberland Pharmaceuticals Q2 Earnings Call Highlights

Cumberland Pharmaceuticals (NASDAQ:CPIX) reported a second-quarter operating loss of $3.1 million as it prepared to transition from a commercial-stage specialty pharmaceutical company into an innovati...